MINNEAPOLIS--(BUSINESS WIRE)--You’ve undoubtedly heard of salmonella, but you may not know it’s super attracted to cancer tumors. Typically associated with food poisoning, salmonella is now the centerpiece of Project Stealth, an innovative cancer treatment aimed at killing tumors without side effects.
Dr. Daniel A. Saltzman, Associate Professor of Surgery and Pediatrics, Chief of the Division of Pediatric Surgery at the University of Minnesota Medical School, and Surgeon-in-Chief at the University of Minnesota Amplatz Children’s Hospital, is conducting this unique research. He is using salmonella, rendered harmless, to deliver a sneak attack of anti-cancer drugs directly into tumor cells – without causing any of the side effects traditionally associated with cancer treatments.
Project Stealth targets a variety of cancers, including brain, breast, colon, lung, neuroblastoma, osteosarcoma and pancreatic. In trials of over 4,000 mice, they have experienced no side effects.
Further, Project Stealth was used on a Golden Retriever named Buddy who had developed bone cancer. When all other options were exhausted, Buddy was referred for treatment using Dr. Saltzman’s research. Not only did Buddy experience no side effects from the treatment, he also has been cancer-free for over 18 months.
Saltzman is now at a point where the research needs gap funding of approximately $250,000.00 per year for the next two years. Minneapolis agencies StoneArch and PineappleRM are partnering with Dr. Saltzman to coordinate the campaign.
Now, the public has an opportunity to contribute to this important research as federal funding for cancer research is at an all time low. One-hundred percent of all donated funds will go directly into research.